Advertisement

Topics

Axcan Pharma Incorporated Company Profile

16:38 EDT 19th September 2017 | BioPortfolio

Axcan is a leading specialty pharmaceutical company within the field of gastroenterology in North America and Europe. Axcan markets a broad line of pharmaceutical products used in the treatment of a variety of gastrointestinal diseases and disorders. In addition to its marketing activities, Axcan carries out research and development of products at an advanced stage of development that it acquires or licenses from third parties. By combining its marketing expertise with its research and development experience, Axcan distinguishes itself from specialty pharmaceutical companies that focus solely on distribution of products and offers potential licensors the prospect of rapidly expanding the potential market for their products.

Location

597 Laurier Boulevard
Mont Saint-Hiliare
J3H 6C4
Canada

Contact

Phone: (450) 467-5138
Fax: (450) 464-9979
Email: axcan@axcan.com


News Articles [2282 Associated News Articles listed on BioPortfolio]

Fosun Pharma, Shanghai Pharma Bid for Arbor Pharma, Deal May Fetch $700 Million

  Life Sciences Jobs   ...

CEO of LEO Pharma on how they are driving collaborations

Précis: Gitte Aabo, CEO, LEO Pharma speaking at eyeforpharma Barcelona on what LEO Pharma are doing to drive collaborations and create more value for patients and healthcare.YouTube URL: ht...

Verona Pharma plc: Verona Pharma to Present at Jefferies 2017 Global Healthcare Conference

May 23, 2017, LONDON - Verona Pharma plc (AIM:VRP) (NASDAQ:VRNA) ('Verona Pharma'), a clinical-stage biopharmaceutical company focused on developing and commercialising innovative therapeutics for...

Verona Pharma plc: Verona Pharma Initiates U.S. Clinical Pharmacokinetic Study for RPL554 Following Acceptance of IND Application by FDA

June 5, 2017, LONDON - Verona Pharma plc (AIM: VRP) (NASDAQ: VRNA) ('Verona Pharma'), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapeutics f...

#jobs #lifescience Assistant Controller – Pharma

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Assistant Controller – Pharma .NJ-Fort Lee, RESPONSIBILITIES: Kforce...

#jobs #lifescience 4D Pharma PLC: Senior Immunologist II (Team Leader) – Aberdeen

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: 4D Pharma PLC: Senior Immunologist II (Team Leader) – Aberdeen . Compet...

Verona Pharma plc: Verona Pharma to Announce Interim Results for Six Months Ended June 30, 2017 and Provide Clinical Development Update

LONDON, Aug. 02, 2017 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM:VRP) (NASDAQ:VRNA) ('Verona Pharma'), a clinical-stage biopharmaceutical company focused on developing and commercializing innovati...

Horizon Pharma Reports 2Q Loss of $209.5M

NewsHorizon Pharma Inc. reported a second-quarter loss of $209.5 million on Monday after reporting a profit in the same period a year earlier.Contributed Author: 

Drugs and Medications [306 Associated Drugs and Medications listed on BioPortfolio]

Fluoride [Libertas Pharma, Inc.]

Fluoride Chewable Tablets 0.5 mg

Fluoride [Libertas Pharma, Inc.]

Fluoride Chewable Tablets 1 mg

Metoprolol tartrate [Med-Health Pharma, LLC]

Metoprolol Tartrate Tablets, USP

Urea [Libertas Pharma, Inc.]

Rx Only 45% Urea Nail Gel In a vehicle containing Camphor, Eucalyptus Oil and Menthol )

Eloxatin [Aventis Pharma Ltd.]

PubMed Articles [33 Associated PubMed Articles listed on BioPortfolio]

The moderating role of absorptive capacity and the differential effects of acquisitions and alliances on Big Pharma firms' innovation performance.

In the context of increased pharmaceutical innovation deficits and Big Pharma blockbusters' patent expirations, this paper examines the moderating role of firms' absorptive capacity in external innova...

Delivering advanced therapies: The big pharma approach.

After two decades of focused development and some recent clinical successes, cell and gene therapy (CGT) is emerging as a promising approach to personalized medicines. Genetically engineered cells as ...

Bioanalytical outsourcing: transitioning from Pharma to CRO.

AI-powered drug discovery captures pharma interest.

Clinical Trials Series - Large Pharma.

Clinical Trials [73 Associated Clinical Trials listed on BioPortfolio]

To Demonstrate the Relative Bioavailability of Sandoz Inc. and UCB Pharma, Inc (Keppra) 750 mg Levetiracetam Tablets In Healthy Adults Volunteers Under Fasting Conditions

To demonstrate the relative bioavailability of Sandoz Inc. and UCB Pharma, Inc (Keppra) 750 mg Levetiracetam tablets in healthy adult volunteers under fasting conditions.

Pharma-Pen (Formerly Innoject) Auto-Injectory TIV

The purpose of this study is to evaluate the safety, effectiveness, and tolerability, of the Pharma-Pen(TM) intramuscular (IM) and subcutaneous (SC) auto-injector systems used by untrained...

A Bioequivalence Study of Cefadroxil From Duricef 1 gm F.C.T (GSK) and Biodroxil 1 gm F.C.T (Novartis Pharma)

Comparative randomized, single dose, two-way crossover open-label study to determine the bioequivalence of Cefadroxil from Duricef 1 gm Film Coated tablets(Smthkline Beecham Egypt,LLC aff...

A Bio-equivalence Study of Sofosbuvir From Sofodelevier 400 mg Film Coated Tablets (Al-debeiky Pharma, Egypt) Versus Sovaldi 400 mg Tablets (Gilead Sciences, Canada)

Comparative randomized, single dose, three way three sequence two treatment partial replicate crossover open-label study to determine the bioequivalence of Sofosbuvir from Sofodelevier 400...

To Demonstrate the Relative Bioavailability of Cilostazol 50 mg Tablets Under Fasting Conditions

To demonstrate the relative bioavailability of Cilostazol 50 mg tablets under fasting conditions.

Companies [753 Associated Companies listed on BioPortfolio]

Axcan Pharma™

Axcan develops, manufactures, markets and distributes gastroenterology products and therapeutic treatments worldwide, while focusing primarily in North America and the European Union. Click on the Axc...

Axcan Pharma Incorporated

Axcan is a leading specialty pharmaceutical company within the field of gastroenterology in North America and Europe. Axcan markets a broad line of pharmaceutical products used in the treatment of a v...

Axcan Pharmaceuticals Incorporated

Axcan is a leading specialty pharmaceutical company within the field of gastroenterology in North America and Europe. Axcan markets a broad line of pharmaceutical products used in the treatment of a v...

H3 Pharma Incorporated

H3 Pharma Inc. is a Venture Pharma focusing on the development of human therapeutic products oriented towards age-related disorders. At H3 Pharma, we aim to be the best at identifying, evaluating and ...

LEO Pharma Inc.

LEO Pharma Inc. is headquartered in Parsippany, New Jersey, and is the U.S. affiliate of Denmark-based LEO Pharma A/S, a global leader in dermatology and critical care with more t...

More Information about "Axcan Pharma Incorporated" on BioPortfolio

We have published hundreds of Axcan Pharma Incorporated news stories on BioPortfolio along with dozens of Axcan Pharma Incorporated Clinical Trials and PubMed Articles about Axcan Pharma Incorporated for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Axcan Pharma Incorporated Companies in our database. You can also find out about relevant Axcan Pharma Incorporated Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topic

Gastroenterology
Astroesophageal Reflux Disease (GERD) Barrett's Esophagus Celiac Disease Cholesterol Crohn's Disease Gastroenterology Hepatitis Hepatology Irritable Bowel Syndrome (IBS) Pancreatitis Peptic Ulcer Disease...


Corporate Database Quicklinks



Searches Linking to this Company Record